Hung-Sheng Lin

445 total citations
32 papers, 342 citations indexed

About

Hung-Sheng Lin is a scholar working on Neurology, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Hung-Sheng Lin has authored 32 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 9 papers in Epidemiology and 6 papers in Psychiatry and Mental health. Recurrent topics in Hung-Sheng Lin's work include Acute Ischemic Stroke Management (8 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Spinal Dysraphism and Malformations (3 papers). Hung-Sheng Lin is often cited by papers focused on Acute Ischemic Stroke Management (8 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Spinal Dysraphism and Malformations (3 papers). Hung-Sheng Lin collaborates with scholars based in Taiwan, China and United States. Hung-Sheng Lin's co-authors include Hon‐Kan Yip, Wen‐Neng Chang, Cheng‐Hsien Lu, Tzu‐Hsien Tsai, Chun-Man Yuen, Steve Leu, Min‐Yu Lan, Chia‐Wei Liou, Wei-Hsi Chen and Hsin‐Ling Yin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Critical Care.

In The Last Decade

Hung-Sheng Lin

31 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hung-Sheng Lin Taiwan 11 85 72 53 49 42 32 342
Stephanie Knippenberg Netherlands 12 60 0.7× 73 1.0× 41 0.8× 42 0.9× 26 0.6× 17 754
Wei-Hsi Chen Taiwan 10 65 0.8× 46 0.6× 21 0.4× 79 1.6× 31 0.7× 49 373
Hua Huang China 14 45 0.5× 81 1.1× 53 1.0× 31 0.6× 22 0.5× 43 468
Dragoş Cătălin Jianu Romania 15 106 1.2× 108 1.5× 46 0.9× 153 3.1× 37 0.9× 75 608
Smaranda Maier Romania 14 71 0.8× 96 1.3× 48 0.9× 153 3.1× 18 0.4× 71 507
Awadh Kishor Pandit India 13 151 1.8× 118 1.6× 72 1.4× 122 2.5× 22 0.5× 63 531
Zoltán Bajkó Romania 14 83 1.0× 78 1.1× 54 1.0× 182 3.7× 20 0.5× 68 592
Tadeusz Mendel Poland 14 106 1.2× 43 0.6× 51 1.0× 151 3.1× 54 1.3× 37 404
Gülhıs Deda Türkiye 14 88 1.0× 79 1.1× 23 0.4× 37 0.8× 157 3.7× 43 446
Isuru Induruwa United Kingdom 9 63 0.7× 50 0.7× 23 0.4× 54 1.1× 107 2.5× 19 450

Countries citing papers authored by Hung-Sheng Lin

Since Specialization
Citations

This map shows the geographic impact of Hung-Sheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung-Sheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung-Sheng Lin more than expected).

Fields of papers citing papers by Hung-Sheng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hung-Sheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung-Sheng Lin. The network helps show where Hung-Sheng Lin may publish in the future.

Co-authorship network of co-authors of Hung-Sheng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hung-Sheng Lin. A scholar is included among the top collaborators of Hung-Sheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung-Sheng Lin. Hung-Sheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Hung-Sheng, Pei‐Hsun Sung, Shu‐Hua Huang, et al.. (2024). Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients—A randomized, open-label, controlled phase II clinical trial. Stem Cell Research & Therapy. 15(1). 443–443. 2 indexed citations
3.
Sung, Pei‐Hsun, Kuan‐Hung Chen, Hung-Sheng Lin, et al.. (2019). The Correlation between Severity of Neurological Impairment and Left Ventricular Function in Patients after Acute Ischemic Stroke. Journal of Clinical Medicine. 8(2). 190–190. 20 indexed citations
4.
Lin, Hung-Sheng, et al.. (2017). Topiramate-associated sexual dysfunction: A systematic review. Epilepsy & Behavior. 73. 10–17. 15 indexed citations
5.
Chen, Wei-Hsi, et al.. (2017). Cheiro-pedal syndrome: A revisit of etiology, localization and outcome. Clinical Neurology and Neurosurgery. 157. 59–64.
6.
Cheng, Cheng‐I, Yu‐Chun Lin, Tzu‐Hsien Tsai, et al.. (2014). The Prognostic Values of Leukocyte Rho Kinase Activity in Acute Ischemic Stroke. BioMed Research International. 2014. 1–11. 9 indexed citations
7.
Chen, Yung‐Lung, Tzu‐Hsien Tsai, Pei‐Hsun Sung, et al.. (2013). Levels of Circulating Neopterin in Patients with Severe Carotid Artery Stenosis Undergoing Carotid Stenting. Journal of Atherosclerosis and Thrombosis. 21(2). 129–139. 4 indexed citations
8.
Lan, Min‐Yu, Yung‐Yee Chang, Wei-Hsi Chen, et al.. (2013). Association between MIF gene polymorphisms and carotid artery atherosclerosis. Biochemical and Biophysical Research Communications. 435(2). 319–322. 17 indexed citations
9.
Chen, Wei-Hsi, et al.. (2012). Salt-and-pepper eye pain and brainstem stroke. Clinical Neurology and Neurosurgery. 114(7). 972–975. 2 indexed citations
10.
Yeh, Kuo‐Ho, Tzu‐Hsien Tsai, Han‐Tan Chai, et al.. (2012). Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin. Journal of Translational Medicine. 10(1). 6–6. 20 indexed citations
11.
Chen, Wei-Hsi, et al.. (2012). Clinical analysis of cheiro-pedal syndrome. Journal of Clinical Neuroscience. 19(7). 991–995. 5 indexed citations
12.
Lin, Hung-Sheng, et al.. (2012). Cheiro-oral syndrome: A reappraisal of the etiology and outcome. 1 indexed citations
13.
Yip, Hon‐Kan, Tzu‐Hsien Tsai, Hung-Sheng Lin, et al.. (2011). Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Critical Care. 15(1). R40–R40. 81 indexed citations
14.
Chen, Wei-Hsi, et al.. (2011). The medicolegal issue of tissue plasminogen activator in ischemic stroke: a review of judiciary decrees in Taiwan.. PubMed. 20(3). 163–71. 8 indexed citations
15.
Lin, Hung-Sheng, et al.. (2011). Spinal cheiro-oral syndrome: a common neurological entity in an unusual site. Neurologia i Neurochirurgia Polska. 45(6). 583–589. 2 indexed citations
16.
Chen, Wei-Hsi, Hsin‐Ling Yin, Hung-Sheng Lin, & Chung‐Jen Chen. (2010). Symptomatic noncompressive motoromyelopathy presents as early manifestation in ankylosing spondylitis. Rheumatology International. 31(7). 945–950. 3 indexed citations
17.
Chen, Wei-Hsi, et al.. (2008). Crossed cheiro-oral syndrome. Clinical Neurology and Neurosurgery. 110(10). 1008–1011. 10 indexed citations
18.
Chen, Wei-Hsi, et al.. (2007). Postoperative parkinsonism and lupus anticoagulant: A model of autoantibody-mediated neurotoxicity in stress. Brain Injury. 21(5). 539–543. 2 indexed citations
19.
Chen, Wei-Hsi, Hsin‐Ling Yin, Hung-Sheng Lin, Shun-Sheng Chen, & Jiashou Liu. (2006). Delayed hypokalemic paralysis following a convulsion due to alcohol abstinence. Journal of Clinical Neuroscience. 13(4). 453–456. 6 indexed citations
20.
Lin, Hung-Sheng, et al.. (2005). Parasagittal hemangioma associates with unilateral cheiro-oral-pedal syndrome. Neurology India. 53(3). 342–342. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026